Annika Stiasny

The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer

C. Alexiou, U. Jeschke, C. Kuhn, 2017, Oncology letters.

Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.

C. Alexiou, U. Jeschke, C. Kuhn, 2016, Anticancer research.

Clinical Evaluation of Mucin-1 (MUC1) and P16 in Laryngeal Cancer

C. Alexiou, U. Jeschke, K. Friese, 2016 .

Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better Prognosis.

C. Alexiou, U. Jeschke, C. Kuhn, 2016, Anticancer research.